• Press Release

The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai

The gift will be used to help fund a large study comparing two and three sessions of MDMA-assisted psychotherapy in combat veterans diagnosed with post-traumatic stress disorder (PTSD). The study is being sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS).

  • New York, NY
  • (July 09, 2021)

The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the  Steven & Alexandra Cohen Foundation. The gift will be used to help fund a large study comparing two and three sessions of MDMA-assisted psychotherapy in combat veterans diagnosed with post-traumatic stress disorder (PTSD). The study is being sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS).

“Psychedelic-assisted psychotherapy represents an entirely new treatment approach for veterans with trauma-related conditions like PTSD and depression,” said Alexandra M. Cohen, President of the Steven & Alexandra Cohen Foundation. “We are excited to support this innovative work and look forward to seeing the potential impact of this study on veterans and their families.”

PTSD and trauma are highly prevalent in our society. More than 70 percent of Americans will experience a major traumatic event in their lifetime. More than 8 million adults are diagnosed with PTSD each year in the United States, and seven to eight out of every 100 Americans will experience PTSD at some point during their lives. PTSD is a particularly significant problem for combat veterans.  Many patients remain with significant PTSD symptoms even after a course of therapy. A recent phase 3 clinical trial sponsored by MAPS demonstrated significant benefits for MDMA-assisted psychotherapy in reducing PTSD symptom severity and promoting sustained wellness. 

“The Steven & Alexandra Cohen Foundation has been at the forefront of philanthropic giving for the benefit of our combat veterans. This generous gift will allow us to dedicate our efforts to studying the effect of MDMA-assisted psychotherapy in combat veterans with PTSD,” says Rachel Yehuda, PhD, Director of Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research. “We are extremely grateful for their support of our mission to revolutionize the treatment of trauma survivors with psychedelic psychotherapy and better understand the mechanisms of resilience and recovery from trauma.”

Under the direction of Dr. Yehuda, The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai examines the therapeutic potential of psychedelic compounds such as MDMA and psilocybin for post-traumatic stress disorder and other trauma-related symptoms. 

About the Steven & Alexandra Cohen Foundation

The Steven & Alexandra Cohen Foundation is committed to inspiring philanthropy and community service by creating awareness, offering guidance, and leading by example to show the world what giving can do. Since launching the Foundation in 2001, Steven and Alexandra Cohen have generously funded local and national nonprofit organizations that uplift the communities in which they serve. The Cohens' giving reflects their personal connection with the causes that inspire them. To learn more, please visit steveandalex.org or follow @CohenGive on FacebookTwitter, and Instagram


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.